{
  "docId": "019de072-1e7f-7432-8113-f418b135b18e",
  "docSlug": "8181c9d0b78b17baf42d7284d4ec3f86",
  "documentTitle": "BioNTech | Investor Day Presentation Deck | 15 slides",
  "authorId": "biontech",
  "authorName": "BioNTech",
  "documentKindSlug": "conference-presentation",
  "documentKindLabel": "Conference presentation",
  "sourceTypeSlug": "investor_relations",
  "sourceTypeLabel": "Investor relations",
  "presentationDate": "2022-02-01 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.7777778,
  "pageNumber": 9,
  "pageCount": 15,
  "prevPage": 8,
  "nextPage": 10,
  "slideType": "key_takeaways",
  "function": "summarize",
  "density": "dense",
  "nDataPoints": 0,
  "notes": null,
  "elementsJson": null,
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019de072-1e7f-7432-8113-f418b135b18e/9",
  "deckHref": "/decks/019de072-1e7f-7432-8113-f418b135b18e",
  "deckJsonHref": "/decks/019de072-1e7f-7432-8113-f418b135b18e.json",
  "deckAnchorHref": "/decks/019de072-1e7f-7432-8113-f418b135b18e#slide-9",
  "components": [
    {
      "bbox": {
        "h": 0.09,
        "w": 0.92,
        "x": 0.04,
        "y": 0.8
      },
      "kind": "callout",
      "text": "Learnings from the COVID-19 pandemic",
      "attrs": null,
      "subkind": "primary",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "d1a10bcc-06a6-49fc-9920-186dc3a90091",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.03,
        "w": 0.1,
        "x": 0.86,
        "y": 0.05
      },
      "kind": "image",
      "text": "BIONTECH",
      "attrs": null,
      "subkind": "logo",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "75fae594-c723-4665-a24e-03ccba52f883",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.25,
        "w": 0.22,
        "x": 0.27,
        "y": 0.49
      },
      "kind": "list",
      "text": "mRNA is a versatile drug class to potentially develop various vaccines",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "56a64cad-f841-4b80-bd43-f10eea5128f7",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.25,
        "w": 0.22,
        "x": 0.51,
        "y": 0.49
      },
      "kind": "list",
      "text": "Technology, automation and digitalization allow for new solutions",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "ad230133-36c5-4431-8742-897edd5ebfc2",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.25,
        "w": 0.22,
        "x": 0.75,
        "y": 0.49
      },
      "kind": "list",
      "text": "The pandemic has shown the power of collaboration and joint efforts",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "bf1f108e-daca-4771-9d06-239fb2d3f358",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.25,
        "w": 0.22,
        "x": 0.04,
        "y": 0.49
      },
      "kind": "list",
      "text": "In a connected world, a global approach is required to address public health issues",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "d39039af-be8d-48c9-bf5a-6bf3b1db7a30",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.07,
        "w": 0.75,
        "x": 0.04,
        "y": 0.07
      },
      "kind": "title",
      "text": "The time is now to facilitate access to mRNA",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "3f17d7cb-3a07-4faa-8dbd-4a4c443cede0",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [],
  "frameworks": [],
  "arcBeats": [
    {
      "to": 9,
      "from": 5,
      "beatId": "915452c1-c3ce-4db7-ac0f-152f19600700",
      "arcName": "Problem-Agitate-Solution",
      "arcSlug": "problem-agitate-solution",
      "beatName": "Solution (Provide relief)",
      "beatSlug": "problem-agitate-solution-solution-provide-relief",
      "evidence": "Slides 5-9 present BioNTainers as a turnkey, scalable solution for mRNA vaccine production",
      "position": 1,
      "confidence": 0.8,
      "parentBeatName": "Resolution",
      "parentBeatSlug": "resolution"
    }
  ],
  "loops": [
    {
      "to": 10,
      "from": 1,
      "name": "Cost Of Inaction",
      "slug": "27-cost-of-inaction",
      "bestFor": "Urgent budget requests, compliance, risk mitigation",
      "matchId": "61ea83e6-0551-414f-8415-15206779cbdd",
      "evidence": "The presentation implies that the cost of inaction is limited access to life-saving vaccines",
      "position": 0,
      "objective": "What is the cost of not facilitating access to mRNA vaccines in Africa?",
      "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point",
      "confidence": 0.7,
      "description": "Quantify what happens if the audience does nothing"
    }
  ],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}